BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tanaka K, Ikeda M, Nozaki A, Kato N, Tsuda H, Saito S, Sekihara H. Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study. Jpn J Cancer Res. 1999;90:367-371. [PMID: 10363572 DOI: 10.1111/j.1349-7006.1999.tb00756.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 73] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Wakabayashi H, Oda H, Yamauchi K, Abe F. Lactoferrin for prevention of common viral infections. J Infect Chemother 2014;20:666-71. [PMID: 25182867 DOI: 10.1016/j.jiac.2014.08.003] [Cited by in Crossref: 101] [Cited by in F6Publishing: 88] [Article Influence: 14.4] [Reference Citation Analysis]
2 Venkatesh M, Abrams S. Can lactoferrin prevent neonatal sepsis and necrotizing enterocolitis? Expert Rev Anti Infect Ther 2009;7:515-25. [PMID: 19485792 DOI: 10.1586/eri.09.25] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
3 Sharma D, Murki A, Murki S, Pratap OT. Use of lactoferrin in the newborn: where do we stand? J Matern Fetal Neonatal Med 2015;28:1774-8. [PMID: 25245229 DOI: 10.3109/14767058.2014.968548] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
4 Berlutti F, Pantanella F, Natalizi T, Frioni A, Paesano R, Polimeni A, Valenti P. Antiviral properties of lactoferrin--a natural immunity molecule. Molecules 2011;16:6992-7018. [PMID: 21847071 DOI: 10.3390/molecules16086992] [Cited by in Crossref: 145] [Cited by in F6Publishing: 125] [Article Influence: 14.5] [Reference Citation Analysis]
5 Kuwata H, Yamauchi K, Teraguchi S, Ushida Y, Shimokawa Y, Toida T, Hayasawa H. Functional fragments of ingested lactoferrin are resistant to proteolytic degradation in the gastrointestinal tract of adult rats. J Nutr 2001;131:2121-7. [PMID: 11481405 DOI: 10.1093/jn/131.8.2121] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 3.1] [Reference Citation Analysis]
6 Yamauchi K, Wakabayashi H, Shin K, Takase M. Bovine lactoferrin: benefits and mechanism of action against infections. Biochem Cell Biol 2006;84:291-6. [PMID: 16936799 DOI: 10.1139/o06-054] [Cited by in Crossref: 71] [Cited by in F6Publishing: 54] [Article Influence: 4.7] [Reference Citation Analysis]
7 Blanchard E, Zhu P, Schuck P. Infant formula powders. Handbook of Food Powders. Elsevier; 2013. pp. 465-83. [DOI: 10.1533/9780857098672.3.465] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
8 Abe K, Nozaki A, Tamura K, Ikeda M, Naka K, Dansako H, Hoshino H, Tanaka K, Kato N. Tandem Repeats of Lactoferrin-Derived Anti-Hepatitis C Virus Peptide Enhance Antiviral Activity in Cultured Human Hepatocytes. Microbiology and Immunology 2007;51:117-25. [DOI: 10.1111/j.1348-0421.2007.tb03882.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
9 Wakabayashi H, Uchida K, Yamauchi K, Teraguchi S, Hayasawa H, Yamaguchi H. Lactoferrin given in food facilitates dermatophytosis cure in guinea pig models. J Antimicrob Chemother 2000;46:595-602. [PMID: 11020258 DOI: 10.1093/jac/46.4.595] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 2.1] [Reference Citation Analysis]
10 Sharma D, Shastri S, Sharma P. Role of lactoferrin in neonatal care: a systematic review. J Matern Fetal Neonatal Med 2017;30:1920-32. [PMID: 27593940 DOI: 10.1080/14767058.2016.1232384] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
11 Pammi M, Abrams SA. Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2015;:CD007137. [PMID: 25699678 DOI: 10.1002/14651858.CD007137.pub4] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
12 Ikeda M, Nozaki A, Sugiyama K, Tanaka T, Naganuma A, Tanaka K, Sekihara H, Shimotohno K, Saito M, Kato N. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells. Virus Research 2000;66:51-63. [DOI: 10.1016/s0168-1702(99)00121-5] [Cited by in Crossref: 95] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
13 Singh R, Geetanjali. Whey Proteins and Their Value-Added Applications. Protein Byproducts. Elsevier; 2016. pp. 303-13. [DOI: 10.1016/b978-0-12-802391-4.00016-1] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
14 Azocar J, Diaz A. Efficacy and safety of Chlorella supplementation in adults with chronic hepatitis C virus infection. World J Gastroenterol 2013; 19(7): 1085-1090 [PMID: 23467073 DOI: 10.3748/wjg.v19.i7.1085] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
15 Shin K, Wakabayashi H, Yamauchi K, Teraguchi S, Tamura Y, Kurokawa M, Shiraki K. Effects of orally administered bovine lactoferrin and lactoperoxidase on influenza virus infection in mice. Journal of Medical Microbiology 2005;54:717-23. [DOI: 10.1099/jmm.0.46018-0] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 4.4] [Reference Citation Analysis]
16 Ravichandran R, Padmanabhan V, Vijayalakhsmi MA, Jayaprakash NS. Studies on recovery of lactoferrin from bovine colostrum whey using mercapto ethyl pyridine and phenyl propyl amine HyperCel™ mixed mode sorbents. Biotechnol Bioproc E 2015;20:148-56. [DOI: 10.1007/s12257-014-0408-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Ishikado A, Imanaka H, Kotani M, Fujita A, Mitsuishi Y, Kanemitsu T, Tamura Y, Makino T. Liposomal lactoferrin induced significant increase of the interferon-alpha (IFN-alpha) producibility in healthy volunteers. Biofactors 2004;21:69-72. [PMID: 15630172 DOI: 10.1002/biof.552210113] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
18 Ueno H, Sato T, Yamamoto S, Tanaka K, Ohkawa S, Takagi H, Yokosuka O, Furuse J, Saito H, Sawaki A, Kasugai H, Osaki Y, Fujiyama S, Sato K, Wakabayashi K, Okusaka T. Randomized, double-blind, placebo-controlled trial of bovine lactoferrin in patients with chronic hepatitis C. Cancer Sci 2006;97:1105-10. [PMID: 16984383 DOI: 10.1111/j.1349-7006.2006.00274.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
19 Kojouri GA, Ebrahimi A, Zaheri M. Zinc and selenium status in cows with dermatophytosis. Comp Clin Pathol 2009;18:283-6. [DOI: 10.1007/s00580-008-0798-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
20 Wakabayashi H, Yamauchi K, Takase M. Lactoferrin research, technology and applications. International Dairy Journal 2006;16:1241-51. [DOI: 10.1016/j.idairyj.2006.06.013] [Cited by in Crossref: 217] [Cited by in F6Publishing: 142] [Article Influence: 14.5] [Reference Citation Analysis]
21 Rodrigues L, Teixeira J, Schmitt F, Paulsson M, Månsson HL. Lactoferrin and cancer disease prevention. Crit Rev Food Sci Nutr 2009;49:203-17. [PMID: 19093266 DOI: 10.1080/10408390701856157] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 4.4] [Reference Citation Analysis]
22 Brink LR, Chichlowski M, Pastor N, Thimmasandra Narayanappa A, Shah N. In the Age of Viral Pandemic, Can Ingredients Inspired by Human Milk and Infant Nutrition Be Repurposed to Support the Immune System? Nutrients 2021;13:870. [PMID: 33800961 DOI: 10.3390/nu13030870] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Venkatesh MP, Abrams SA. Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2010;:CD007137. [PMID: 20464748 DOI: 10.1002/14651858.CD007137.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
24 Pammi M, Suresh G. Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2017;6:CD007137. [PMID: 28658720 DOI: 10.1002/14651858.CD007137.pub5] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 11.3] [Reference Citation Analysis]
25 Nozaki A, Ikeda M, Naganuma A, Nakamura T, Inudoh M, Tanaka K, Kato N. Identification of a Lactoferrin-derived Peptide Possessing Binding Activity to Hepatitis C Virus E2 Envelope Protein. Journal of Biological Chemistry 2003;278:10162-73. [DOI: 10.1074/jbc.m207879200] [Cited by in Crossref: 41] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
26 Pammi M, Abrams SA. Enteral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates. Cochrane Database Syst Rev 2019;5:CD007138. [PMID: 31077334 DOI: 10.1002/14651858.CD007138.pub4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
27 Picard-Jean F, Bouchard S, Larivée G, Bisaillon M. The intracellular inhibition of HCV replication represents a novel mechanism of action by the innate immune Lactoferrin protein. Antiviral Res 2014;111:13-22. [PMID: 25193851 DOI: 10.1016/j.antiviral.2014.08.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
28 Pammi M, Abrams SA. Oral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates. Cochrane Database Syst Rev 2011;:CD007138. [PMID: 21975766 DOI: 10.1002/14651858.CD007138.pub3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
29 Sharma D, Shastri S. Lactoferrin and neonatology – role in neonatal sepsis and necrotizing enterocolitis: present, past and future. The Journal of Maternal-Fetal & Neonatal Medicine 2015;29:763-70. [DOI: 10.3109/14767058.2015.1017463] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
30 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on bovine lactoferrin: Safety of ‘Bovine Lactoferrin’. EFSA Journal 2012;10:2701. [DOI: 10.2903/j.efsa.2012.2701] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
31 Flaim C, Kob M, Di Pierro AM, Herrmann M, Lucchin L. Effects of a whey protein supplementation on oxidative stress, body composition and glucose metabolism among overweight people affected by diabetes mellitus or impaired fasting glucose: A pilot study. J Nutr Biochem 2017;50:95-102. [PMID: 29053995 DOI: 10.1016/j.jnutbio.2017.05.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
32 Kume H, Okazaki K, Sasaki H. Hepatoprotective effects of whey protein on D-galactosamine-induced hepatitis and liver fibrosis in rats. Biosci Biotechnol Biochem 2006;70:1281-5. [PMID: 16717438 DOI: 10.1271/bbb.70.1281] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
33 Giansanti F, Panella G, Leboffe L, Antonini G. Lactoferrin from Milk: Nutraceutical and Pharmacological Properties. Pharmaceuticals (Basel) 2016;9:E61. [PMID: 27690059 DOI: 10.3390/ph9040061] [Cited by in Crossref: 84] [Cited by in F6Publishing: 67] [Article Influence: 16.8] [Reference Citation Analysis]
34 Yamauchi K, Toida T, Nishimura S, Nagano E, Kusuoka O, Teraguchi S, Hayasawa H, Shimamura S, Tomita M. 13-Week oral repeated administration toxicity study of bovine lactoferrin in rats. Food and Chemical Toxicology 2000;38:503-12. [DOI: 10.1016/s0278-6915(00)00036-3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
35 Ahmed A, Siman-Tov G, Hall G, Bhalla N, Narayanan A. Human Antimicrobial Peptides as Therapeutics for Viral Infections. Viruses 2019;11:E704. [PMID: 31374901 DOI: 10.3390/v11080704] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 37.5] [Reference Citation Analysis]
36 Kuhara T, Tanaka A, Yamauchi K, Iwatsuki K. Bovine lactoferrin ingestion protects against inflammation via IL-11 induction in the small intestine of mice with hepatitis. Br J Nutr 2014;111:1801-10. [PMID: 24472388 DOI: 10.1017/S0007114513004315] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
37 Pammi M, Abrams SA. Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2011;:CD007137. [PMID: 21975765 DOI: 10.1002/14651858.CD007137.pub3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
38 Kaito M, Iwasa M, Fujita N, Kobayashi Y, Kojima Y, Ikoma J, Imoto I, Adachi Y, Hamano H, Yamauchi K. Effect of lactoferrin in patients with chronic hepatitis C: combination therapy with interferon and ribavirin. J Gastroenterol Hepatol 2007;22:1894-7. [PMID: 17914966 DOI: 10.1111/j.1440-1746.2007.04858.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
39 Superti F. Lactoferrin from Bovine Milk: A Protective Companion for Life. Nutrients 2020;12:E2562. [PMID: 32847014 DOI: 10.3390/nu12092562] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
40 Shin DH, Martinez SS, Parsons M, Jayaweera DT, Campa A, Baum MK. Relationship of Oxidative Stress with HIV Disease Progression in HIV/HCV Co-infected and HIV Mono-infected Adults in Miami. Int J Biosci Biochem Bioinforma 2012;2:217-23. [PMID: 23504530 DOI: 10.7763/ijbbb.2012.v2.104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
41 Kuhara T, Yamauchi K, Tamura Y, Okamura H. Oral administration of lactoferrin increases NK cell activity in mice via increased production of IL-18 and type I IFN in the small intestine. J Interferon Cytokine Res 2006;26:489-99. [PMID: 16800788 DOI: 10.1089/jir.2006.26.489] [Cited by in Crossref: 76] [Cited by in F6Publishing: 61] [Article Influence: 5.1] [Reference Citation Analysis]
42 Iwasa M, Kaito M, Ikoma J, Takeo M, Imoto I, Adachi Y, Yamauchi K, Koizumi R, Teraguchi S. Lactoferrin inhibits hepatitis C virus viremia in chronic hepatitis C patients with high viral loads and HCV genotype 1b. Am J Gastroenterology 2002;97:766-7. [DOI: 10.1111/j.1572-0241.2002.05573.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 2.5] [Reference Citation Analysis]
43 Okada S, Tanaka K, Sato T, Ueno H, Saito S, Okusaka T, Sato K, Yamamoto S, Kakizoe T. Dose-response trial of lactoferrin in patients with chronic hepatitis C. Jpn J Cancer Res 2002;93:1063-9. [PMID: 12359061 DOI: 10.1111/j.1349-7006.2002.tb02484.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
44 Elattar G, Saleh Z, El-Shebini S, Farrag A, Zoheiry M, Hassanein A, El-Ghannam M, Shendy S, El-Dabaa E, Zahran N. The use of whey protein concentrate in management of chronic hepatitis C virus - a pilot study. Arch Med Sci 2010;6:748-55. [PMID: 22419935 DOI: 10.5114/aoms.2010.17091] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
45 Pammi M, Suresh G. Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2020;3:CD007137. [PMID: 32232984 DOI: 10.1002/14651858.CD007137.pub6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 14.0] [Reference Citation Analysis]
46 Kuhara T, Yamauchi K, Iwatsuki K. Bovine lactoferrin induces interleukin-11 production in a hepatitis mouse model and human intestinal myofibroblasts. Eur J Nutr 2012;51:343-51. [PMID: 21688123 DOI: 10.1007/s00394-011-0219-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
47 . Lactoferrin. Arbor Clin Nutr Updates 2006;263:1-3. [DOI: 10.1017/s1446545000000774] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
48 Wakabayashi H, Takakura N, Yamauchi K, Tamura Y. Modulation of immunity-related gene expression in small intestines of mice by oral administration of lactoferrin. Clin Vaccine Immunol 2006;13:239-45. [PMID: 16467332 DOI: 10.1128/CVI.13.2.239-245.2006] [Cited by in Crossref: 42] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
49 Tamura T, Nozaki A, Abe K, Dansako H, Naka K, Ikeda M, Tanaka K, Kato N. cDNA microarray analysis of lactoferrin expression in non-neoplastic human hepatocyte PH5CH8 cells. Biochim Biophys Acta 2005;1721:73-80. [PMID: 15652181 DOI: 10.1016/j.bbagen.2004.10.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
50 Liao Y, El-Fakkarany E, Lönnerdal B, Redwan EM. Inhibitory effects of native and recombinant full-length camel lactoferrin and its N and C lobes on hepatitis C virus infection of Huh7.5 cells. J Med Microbiol 2012;61:375-83. [PMID: 22052996 DOI: 10.1099/jmm.0.033894-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
51 Sarin S. What should we advise about adjunctive therapies, including herbal medicines, for hepatitis C? J Gastroenterol Hepatol 2000;15:E164-71. [DOI: 10.1046/j.1440-1746.2000.02117.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
52 Valenti P, Berlutti F, Conte MP, Longhi C, Seganti L. Lactoferrin Functions: Current Status and Perspectives. Journal of Clinical Gastroenterology 2004;38:S127-9. [DOI: 10.1097/01.mcg.0000128941.46881.33] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 2.8] [Reference Citation Analysis]
53 Carrillo W, Monteiro KM, Spindola H, Ramos M, de Carvalho JE. Antiulcerative and Antinociceptive Activities of Casein and Whey Proteins. Journal of Medicinal Food 2018;21:605-11. [DOI: 10.1089/jmf.2017.0090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Fischer R, Debbabi H, Dubarry M, Boyaka P, Tomé D. Regulation of physiological and pathological Th1 and Th2 responses by lactoferrin. Biochem Cell Biol. 2006;84:303-311. [PMID: 16936801 DOI: 10.1139/o06-058] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 3.7] [Reference Citation Analysis]
55 Kakizoe T. Asian studies of cancer chemoprevention: latest clinical results. Eur J Cancer. 2000;36:1303-1309. [PMID: 10882871 DOI: 10.1016/s0959-8049(00)00107-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
56 Vorland LH. Lactoferrin: A multifunctional glycoprotein. APMIS 1999;107:971-81. [DOI: 10.1111/j.1699-0463.1999.tb01499.x] [Cited by in Crossref: 168] [Cited by in F6Publishing: 151] [Article Influence: 7.6] [Reference Citation Analysis]
57 Campione E, Lanna C, Cosio T, Rosa L, Conte MP, Iacovelli F, Romeo A, Falconi M, Del Vecchio C, Franchin E, Lia MS, Minieri M, Chiaramonte C, Ciotti M, Nuccetelli M, Terrinoni A, Iannuzzi I, Coppeda L, Magrini A, Bernardini S, Sabatini S, Rosapepe F, Bartoletti PL, Moricca N, Di Lorenzo A, Andreoni M, Sarmati L, Miani A, Piscitelli P, Valenti P, Bianchi L. Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences. Front Pharmacol 2021;12:666600. [PMID: 34220505 DOI: 10.3389/fphar.2021.666600] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
58 Ahmad S. Buffalo Milk. In: Park YW, Haenlein GF, editors. Milk and Dairy Products in Human Nutrition. Oxford: John Wiley & Sons; 2013. pp. 519-53. [DOI: 10.1002/9781118534168.ch24] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
59 Tomita M, Wakabayashi H, Yamauchi K, Teraguchi S, Hayasawa H. Bovine lactoferrin and lactoferricin derived from milk: production and applications. Biochem Cell Biol 2002;80:109-12. [PMID: 11908633 DOI: 10.1139/o01-230] [Cited by in Crossref: 136] [Cited by in F6Publishing: 120] [Article Influence: 7.2] [Reference Citation Analysis]
60 Pietrantoni A, Dofrelli E, Tinari A, Ammendolia MG, Puzelli S, Fabiani C, Donatelli I, Superti F. Bovine lactoferrin inhibits influenza A virus induced programmed cell death in vitro. Biometals 2010;23:465-75. [PMID: 20232110 DOI: 10.1007/s10534-010-9323-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
61 Li S, Zhou H, Huang G, Liu N. Inhibition of HBV infection by bovine lactoferrin and iron-, zinc-saturated lactoferrin. Med Microbiol Immunol. 2009;198:19-25. [PMID: 18810491 DOI: 10.1007/s00430-008-0100-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
62 Sinopoli A, Isonne C, Santoro MM, Baccolini V. The effects of orally administered lactoferrin in the prevention and management of viral infections: A systematic review. Rev Med Virol 2021;:e2261. [PMID: 34133812 DOI: 10.1002/rmv.2261] [Reference Citation Analysis]
63 Mohan P, Abrams SA. Oral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates. Cochrane Database Syst Rev 2009;:CD007138. [PMID: 19160324 DOI: 10.1002/14651858.CD007138.pub2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
64 Tsuda H, Sekine K, Fujita K, Iigo M. Cancer prevention by bovine lactoferrin and underlying mechanisms — a review of experimental and clinical studies. Biochem Cell Biol 2002;80:131-6. [DOI: 10.1139/o01-239] [Cited by in Crossref: 107] [Cited by in F6Publishing: 89] [Article Influence: 5.6] [Reference Citation Analysis]
65 Mancinelli R, Rosa L, Cutone A, Lepanto MS, Franchitto A, Onori P, Gaudio E, Valenti P. Viral Hepatitis and Iron Dysregulation: Molecular Pathways and the Role of Lactoferrin. Molecules 2020;25:E1997. [PMID: 32344579 DOI: 10.3390/molecules25081997] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
66 Wakabayashi H, Takakura N, Yamauchi K, Teraguchi S, Uchida K, Yamaguchi H, Tamura Y. Effect of lactoferrin feeding on the host antifungal response in guinea-pigs infected or immunised with Trichophyton mentagrophytes. Journal of Medical Microbiology 2002;51:844-50. [DOI: 10.1099/0022-1317-51-10-844] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
67 Kolb AF. The prospects of modifying the antimicrobial properties of milk. Biotechnol Adv 2001;19:299-316. [PMID: 14538078 DOI: 10.1016/s0734-9750(01)00069-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
68 Lingappan K, Arunachalam A, Pammi M. Lactoferrin and the newborn: current perspectives. Expert Rev Anti Infect Ther 2013;11:695-707. [PMID: 23879609 DOI: 10.1586/14787210.2013.811927] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
69 Wakabayashi H, Takakura N, Teraguchi S, Tamura Y. Lactoferrin Feeding Augments Peritoneal Macrophage Activities in Mice Intraperitoneally Injected with Inactivated Candida albicans. Microbiology and Immunology 2003;47:37-43. [DOI: 10.1111/j.1348-0421.2003.tb02783.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
70 Tanaka T, Kawabata K, Kohno H, Honjo S, Murakami M, Ota T, Tsuda H. Chemopreventive effect of bovine lactoferrin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats. Jpn J Cancer Res 2000;91:25-33. [PMID: 10744041 DOI: 10.1111/j.1349-7006.2000.tb00856.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 1.7] [Reference Citation Analysis]
71 Roy M, Kuwabara Y, Hara K, Watanabe Y, Tamai Y. Peptides From the N-terminal End of Bovine Lactoferrin Induce Apoptosis in Human Leukemic (HL-60) Cells. Journal of Dairy Science 2002;85:2065-74. [DOI: 10.3168/jds.s0022-0302(02)74284-7] [Cited by in Crossref: 50] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
72 Weinberg ED. Human lactoferrin: a novel therapeutic with broad spectrum potential. J Pharm Pharmacol 2001;53:1303-10. [PMID: 11697537 DOI: 10.1211/0022357011777792] [Cited by in Crossref: 85] [Cited by in F6Publishing: 83] [Article Influence: 4.5] [Reference Citation Analysis]
73 van’t Land B, Boehm G, Garssen J. Breast Milk: Components with Immune Modulating Potential and Their Possible Role in Immune Mediated Disease Resistance. In: Watson RR, Zibadi S, Preedy VR, editors. Dietary Components and Immune Function. Totowa: Humana Press; 2010. pp. 25-41. [DOI: 10.1007/978-1-60761-061-8_2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]